Research programme: brain aminopeptidase A inhibitors - Quantum GenomicsAlternative Names: QGC-006
Latest Information Update: 01 Sep 2016
At a glance
- Originator Quantum Genomics
- Class Amines; Disulfides; Sulfonic acids
- Mechanism of Action Glutamyl aminopeptidase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Hypertension
Most Recent Events
- 29 Aug 2016 Early research in Hypertension in France before August 2016 (Quantum Genomics pipeline, August 2016)